Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients

Ferrer Miquel, Torres Antoni

Source: Eur Respir J 2016; 47: 1060-1061
Journal Issue: April
Disease area: Respiratory critical care, Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ferrer Miquel, Torres Antoni. Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients. Eur Respir J 2016; 47: 1060-1061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007



Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003



How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Preventing ventilator-associated pneumonia
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017


Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Nebulised colistin for ventilator-associated pneumonia prevention
Source: Eur Respir J 2015; 46: 1732-1739
Year: 2015



Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007



Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009



Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Source: Eur Respir J 2007; 30: 314-320
Year: 2007



Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Tracheotomy and ventilator-associated pneumonia: the importance of oral care
Source: Eur Respir J 2008; 31: 221
Year: 2008


Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury
Source: Eur Respir J 2016; 47: 1219-1228
Year: 2016



Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011

Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Strategies for de-escalation of therapy in patients with hospital-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007

Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients
Source: Eur Respir J 2010; 35: 795-804
Year: 2010



Evidence on measures for the prevention of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1193-1207
Year: 2007